Access cutting-edge choroidal melanoma treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access choroidal melanoma specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related choroidal melanoma treatment provided free
The primary objective is to determine the safety and efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma (CM).
Sponsor: Aura Biosciences
Check if you qualify for this choroidal melanoma clinical trial in Atlanta, GA
If you're searching for choroidal melanoma treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced choroidal melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.